Department of Community Medicine and School of Public Health, PGIMER, Chandigarh 160012, India.
Department of Community Medicine, JIPMER, Puducherry 605006, India.
Health Policy Plan. 2022 Oct 12;37(9):1116-1128. doi: 10.1093/heapol/czac057.
The share of expenditure on medicines as part of the total out-of-pocket (OOP) expenditure on healthcare services has been reported to be much higher in India than in other countries. This study was conducted to ascertain the extent of this share of medicine expenditure using a novel methodology. OOP expenditure data were collected through exit interviews with 5252 out-patient department patients in three states of India. Follow-up interviews were conducted after Days 1 and 15 of the baseline to identify any additional expenditure incurred. In addition, medicine prescription data were collected from the patients through prescription audits. Self-reported expenditure on medicines was compared with the amount imputed using local market prices based on prescription data. The results were also compared with the mean expenditure on medicines per spell of ailment among non-hospitalized cases from the National Sample Survey (NSS) 75th round for the corresponding states and districts, which is based on household survey methodology. The share of medicines in OOP expenditure did not change significantly for organized private hospitals using the patient-reported vs imputation-based methods (30.74-29.61%). Large reductions were observed for single-doctor clinics, especially in the case of 'Ayurvedic' (64.51-36.51%) and homeopathic (57.53-42.74%) practitioners. After adjustment for socio-demographic factors and types of ailments, we found that household data collection as per NSS methodology leads to an increase of 25% and 26% in the reported share of medicines for public- and private-sector out-patient consultations respectively, as compared with facility-based exit interviews with the imputation of expenditure for medicines as per actual quantity and price data. The nature of healthcare transactions at single-doctor clinics in rural India leads to an over-reporting of expenditure on medicines by patients. While household surveys are valid to provide total expenditure, these are less likely to correctly estimate the share of medicine expenditure.
印度的医疗服务自付支出中,药品支出占比高于其他国家。本研究采用新方法,旨在明确该部分药品支出的占比。通过对印度三个邦的 5252 名门诊患者进行门诊访谈收集自付支出数据。在基线第 1 天和第 15 天进行随访访谈,以确定是否有额外支出。此外,通过处方审核从患者处收集药品处方数据。基于处方数据和当地市场价格估算药品支出,并与患者报告的支出进行比较。研究结果还与国家抽样调查(NSS)第 75 轮相应邦和区非住院病例的药品支出均值进行比较,后者基于家庭调查方法。使用患者报告和估算值两种方法,私立医院的药品自付支出占比变化不大(30.74%29.61%)。单医生诊所的降幅较大,尤其是阿育吠陀(64.51%36.51%)和顺势疗法(57.53%~42.74%)医生。调整社会人口因素和疾病类型后,我们发现,与基于机构的访谈和根据实际数量及价格数据估算支出相比,NSS 方法的家庭数据收集会使公共和私营部门门诊就诊的报告药品支出占比分别增加 25%和 26%。印度农村单医生诊所的医疗交易性质导致患者报告的药品支出过高。家庭调查可准确提供总支出,但不太可能正确估计药品支出占比。